Clinical Trial Update: Voxelotor Sickle Cell Exercise Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for voxelotor in sickle cell anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Voxelotor (voxelotor)

Snippet

Sponsor: Elizabeth Yang, MD, PhD | Conditions: Sickle Cell Anemia | Phase 4 | Status: COMPLETED